Lemonade Stock Surges Over 9% on Analyst Optimism
Lemonade (LMND) shares rallied more than 9% Wednesday, sharply outpacing the broader market's modest 0.3% gain. The surge followed two bullish analyst actions highlighting the insurtech firm's growth potential.
Cantor Fitzgerald initiated coverage with an overweight rating and $60 price target, citing Lemonade's disruptive technology. Meanwhile, another analyst raised their price target to $37 from $30, though maintained a sell rating over leverage concerns.
The divergent views reflect Lemonade's complex investment case - its innovative platform drives premium retention and revenue growth, but balance sheet risks remain. The stock's volatility underscores the market's struggle to value this next-generation insurer.